Table 1.
Patients N = 194 | Controls N = 273 | P‐value | |
---|---|---|---|
Age (y; median, range) | 56 (21‐72) | 25 (18‐86) | <.001 |
Male (n, %) | 115 (59%) | 137 (50%) | .05 |
Smoker (n,%) | 26 (13%) | 37 (14%) | n.s. |
Lives alone | 26 (13%) | 51 (19%) | n.s. |
Children in household | 50 (26%) | 26 (10%) | <.001 |
Vaccinated against influenza | 47 (24%) | 68 (25%) | n.s. |
Duration since SCT (d; median, range) | 679 (23‐9936) | ||
GvHD at time of sampling (n, %) | 72 (37%) | ||
Immunosuppression at time of sampling (n, %) | 119 (61%) |
Abbreviations: GvHD, graft‐vs‐host disease; SCT, allogeneic stem‐cell transplantation.